Detalhe da pesquisa
1.
Epigenetic control over the cell-intrinsic immune response antagonizes self-renewal in acute myeloid leukemia.
Blood
; 143(22): 2284-2299, 2024 May 30.
Artigo
Inglês
| MEDLINE | ID: mdl-38457355
2.
Splicing factor YBX1 mediates persistence of JAK2-mutated neoplasms.
Nature
; 588(7836): 157-163, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33239784
3.
PLCG1 is required for AML1-ETO leukemia stem cell self-renewal.
Blood
; 139(7): 1080-1097, 2022 02 17.
Artigo
Inglês
| MEDLINE | ID: mdl-34695195
4.
Combined proteomics and CRISPRâCas9 screens in PDX identify ADAM10 as essential for leukemia in vivo.
Mol Cancer
; 22(1): 107, 2023 07 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37422628
5.
Immunoproteasome function maintains oncogenic gene expression in KMT2A-complex driven leukemia.
Mol Cancer
; 22(1): 196, 2023 12 04.
Artigo
Inglês
| MEDLINE | ID: mdl-38049829
6.
Unique ligand and kinase-independent roles of the insulin receptor in regulation of cell cycle, senescence and apoptosis.
Nat Commun
; 14(1): 57, 2023 01 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36599833
7.
Low level of antioxidant capacity biomarkers but not target overexpression predicts vulnerability to ROS-inducing drugs.
Redox Biol
; 62: 102639, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36958250
8.
Histone demethylase KDM4C is a functional dependency in JAK2-mutated neoplasms.
Leukemia
; 36(7): 1843-1849, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35654819
9.
Adverse stem cell clones within a single patient's tumor predict clinical outcome in AML patients.
J Hematol Oncol
; 15(1): 25, 2022 03 12.
Artigo
Inglês
| MEDLINE | ID: mdl-35279202
10.
Presence of the GFI1-36N single nucleotide polymorphism enhances the response of MLL-AF9 leukemic cells to CDK4/6 inhibition.
Front Oncol
; 12: 903691, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36003783
11.
HIP1R and vimentin immunohistochemistry predict 1p/19q status in IDH-mutant glioma.
Neuro Oncol
; 24(12): 2121-2132, 2022 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35511748
12.
In vivo PDX CRISPR/Cas9 screens reveal mutual therapeutic targets to overcome heterogeneous acquired chemo-resistance.
Leukemia
; 36(12): 2863-2874, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36333584
13.
YBX1 mediates translation of oncogenic transcripts to control cell competition in AML.
Leukemia
; 36(2): 426-437, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34465866
14.
The proteogenomic subtypes of acute myeloid leukemia.
Cancer Cell
; 40(3): 301-317.e12, 2022 03 14.
Artigo
Inglês
| MEDLINE | ID: mdl-35245447
15.
Signaling defects associated with insulin resistance in nondiabetic and diabetic individuals and modification by sex.
J Clin Invest
; 131(21)2021 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34506305
16.
A Cell-Autonomous Signature of Dysregulated Protein Phosphorylation Underlies Muscle Insulin Resistance in Type 2 Diabetes.
Cell Metab
; 32(5): 844-859.e5, 2020 11 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32888406
17.
ABCB6 RNA expression in leukemias--expression is low in acute promyelocytic leukemia and FLT3-ITD-positive acute myeloid leukemia.
Ann Hematol
; 93(3): 509-12, 2014 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-23793916
18.
Synergistic killing of FLT3ITD-positive AML cells by combined inhibition of tyrosine-kinase activity and N-glycosylation.
Oncotarget
; 8(16): 26613-26624, 2017 Apr 18.
Artigo
Inglês
| MEDLINE | ID: mdl-28460451
19.
Nuclear membrane-localised NOX4D generates pro-survival ROS in FLT3-ITD-expressing AML.
Oncotarget
; 8(62): 105440-105457, 2017 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29285262
20.
NOX-driven ROS formation in cell transformation of FLT3-ITD-positive AML.
Exp Hematol
; 44(12): 1113-1122, 2016 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-27666490